Loading
Loading
Product image is a representation — actual packaging and label may vary.
Nasal Sprays · 7ml
🕐 Pre-order — ships from 31 August 2026
This product is pre-order only right now. Your order will be dispatched once stock arrives on 31 August 2026.
$106
AUD · 1 pack
Flat rate · ships with your order
Selank is a synthetic heptapeptide analog of tuftsin studied in preclinical and clinical research for its anxiolytic and nootropic properties. Research has examined its potential to alleviate anxiety and stress, regulate emotional balance, reduce depressive symptoms, and improve memory and attention including in age-related cognitive impairment. Studies have also explored its immune-modulating properties and enhanced antiviral capabilities.
Chemical Properties
Research Use Only — Disclaimer
These consumable supplies are intended solely for use in research and laboratory settings. All items are sterile and individually packaged for professional handling. BAC water is for peptide reconstitution purposes only and is not intended for injection without appropriate professional supervision. Not for human or animal consumption in any form.
Selank
Selank (TP-7) is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the endogenous tetrapeptide tuftsin, with a Pro-Gly-Pro extension for metabolic stability. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it is approved in Russia as an anxiolytic medication. Its profile is distinct from classical anxiolytics — it shows anxiolytic activity without sedation, dependence, or withdrawal effects in reported studies.
Selank's anxiolytic effects involve modulation of the GABA-A receptor system, although it does not bind directly to the benzodiazepine site. It also inhibits enkephalinase activity — the enzyme responsible for degrading endogenous enkephalins — effectively extending their anxiolytic duration. Selank upregulates BDNF expression in hippocampal tissue and modulates IL-6 and other cytokines, linking its nootropic and immunomodulatory properties.
Russian-language clinical studies describe Selank's efficacy in generalised anxiety disorder, phobic disorder, and asthenic conditions. Nootropic applications studied include working memory improvement and stress-resilience enhancement. Immune-modulating properties have been investigated in models of viral infection and immune deficiency states. NA-Selank (N-acetyl Selank) is a variant with modified N-terminal acylation studied for enhanced nasal bioavailability.
Key References
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
